238 Trials and counting – Where next for IPC research?

How much has infection prevention research really advanced over the past two decades, and are we generating the evidence needed to change clinical practice?

In this episode of Infection Control Matters, we explore two bibliometric reviews examining the landscape of infection prevention and control (IPC) research. Joining Brett are Peta Tehan from Monash University and Georgia Matterson from Avondale University, who discuss their work mapping randomised controlled trials (RCTs) in IPC internationally and the broader landscape of Australian infection prevention research.

The findings reveal encouraging growth, with 239 RCTs identified globally and 841 IPC research publications from Australia over the past 20 years. But the numbers also highlight important gaps. Research is concentrated in particular areas, some critical topics remain underrepresented, and experimental studies still represent a relatively small proportion of the Australian research output.

We discuss the importance of research collaboration, the challenges of conducting multicentre trials, the role of AI in mapping research themes, and why publishing high-quality evidence – including studies that find no benefit – matters.

Papers we discuss:

  1. Mitchell BG, Matterson G, Carroll MR, Donnelly H, Marimuthu K, Tehan PE. Global randomised controlled trials in infection prevention and control: a bibliographic review from the past two decades. J Hosp Infect 2026;174:459–65. https://doi.org/10.1016/j.jhin.2026.03.037.
  2. Mitchell BG, Matterson G, Carroll MR, Stewardson AJ, Tehan PE. Australian research in infection prevention and control: A bibliometric review from the past two decades. Infect Dis Health 2026;31(4):100450. https://doi.org/10.1016/j.idh.2026.100450.